ESSA Pharma Revenue vs. Cash Per Share
| EPIX Stock | USD 1.83 0.07 3.98% |
Total Revenue | First Reported 2013-09-30 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 32.71398089 |
For ESSA Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ESSA Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ESSA Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ESSA Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ESSA Pharma over time as well as its relative position and ranking within its peers.
ESSA |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ESSA Pharma Cash Per Share vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining ESSA Pharma's current stock value. Our valuation model uses many indicators to compare ESSA Pharma value to that of its competitors to determine the firm's financial worth. ESSA Pharma is currently under evaluation in revenue category among its peers. It is one of the top stocks in cash per share category among its peers . At this time, ESSA Pharma's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ESSA Pharma's earnings, one of the primary drivers of an investment's value.ESSA Revenue vs. Competition
ESSA Pharma is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 99.06 Million. ESSA Pharma adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.
ESSA Cash Per Share vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
ESSA Pharma |
| = | null |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
ESSA Pharma |
| = | 3.96 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
ESSA Cash Per Share Comparison
ESSA Pharma is currently under evaluation in cash per share category among its peers.
ESSA Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in ESSA Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ESSA Pharma will eventually generate negative long term returns. The profitability progress is the general direction of ESSA Pharma's change in net profit over the period of time. It can combine multiple indicators of ESSA Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.9 M | -1.8 M | |
| Operating Income | -28.9 M | -27.5 M | |
| Net Loss | -23.9 M | -25.1 M | |
| Income Before Tax | -23.9 M | -25.1 M | |
| Total Other Income Expense Net | 6.4 M | 6.7 M | |
| Net Loss | -31.6 M | -30 M | |
| Net Loss | -23.9 M | -25.1 M | |
| Income Tax Expense | 1.4 K | 1.4 K | |
| Interest Income | 6.4 M | 6.7 M | |
| Net Interest Income | 6.4 M | 6.7 M | |
| Change To Netincome | 8.1 M | 8.5 M | |
| Net Loss | (2.65) | (2.78) | |
| Income Quality | 0.94 | 1.28 | |
| Net Income Per E B T | 1.15 | 1.10 |
ESSA Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on ESSA Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ESSA Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ESSA Pharma's important profitability drivers and their relationship over time.
Use ESSA Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ESSA Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will appreciate offsetting losses from the drop in the long position's value.ESSA Pharma Pair Trading
ESSA Pharma Pair Trading Analysis
The ability to find closely correlated positions to ESSA Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ESSA Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ESSA Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ESSA Pharma to buy it.
The correlation of ESSA Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ESSA Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ESSA Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ESSA Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your ESSA Pharma position
In addition to having ESSA Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.